Agilent Technologies, Inc.: Form 10-K for the period ended Oct 31, 2022
Filed with the SEC on Dec 21, 2022 and accepted by EDGAR at Dec 20, 2022, 18:42 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-11-01 to 2022-10-31 | $6.85bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2021-11-01 to 2022-10-31 | $3.13bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months2021-11-01 to 2022-10-31 | $467.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2021-11-01 to 2022-10-31 | $1.64bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-11-01 to 2022-10-31 | $1.62bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-11-01 to 2022-10-31 | $84.0m | us-gaap:InterestExpense |
| Income tax | 12 months2021-11-01 to 2022-10-31 | $250.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-11-01 to 2022-10-31 | $1.25bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-11-01 to 2022-10-31 | $4.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-11-01 to 2022-10-31 | $4.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-11-01 to 2022-10-31 | 300,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-11-01 to 2022-10-31 | $1.31bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-11-01 to 2022-10-31 | $291.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2021-11-01 to 2022-10-31 | $250.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2021-11-01 to 2022-10-31 | $1.14bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-10-31 | $1.05bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-10-31 | $3.78bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-10-31 | $10.53bn | us-gaap:Assets |
| Current liabilities | At period end2022-10-31 | $1.86bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-10-31 | $5.23bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-10-31 | $2.73bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2022-10-31 | $36.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-10-31 | $5.30bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-22-000026. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.